Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I did - it doesn't matter
It's a 'visible' problem now
My point
The ship will soon collapse... October 2019
Black Leaders Denounce Juul’s $7.5 Million Gift to Medical School
https://www.nytimes.com/2019/06/19/science/juul-meharry-grant-vaping.html
Just requested from local library... they still exist... thank you
Latest Altria Acquisition Bolsters Its Smokeless Segment
https://www.fool.com/investing/2019/06/17/latest-altria-acquisition-bolsters-its-smokeless-s.aspx
Keep investing you POS... you're going out of tobacco business
What the hell is Natural Good Medicines? When was any collaboration announced? Looks like a crap website.
https://www.xxiicentury.com/xxii2015/wp-content/uploads/2019/06/XXII_2019-06-12.pdf
Natural Good Medicines (NGM)
Interesting article posted on Stocktwits: https://www.cnbc.com/2019/06/17/morgan-stanley-predicts-maximum-nicotine-policy-could-halve-tobacco-profits.html
I believe the author has it all wrong... 2035? 2025?... Try October 2020...
Please elaborate.
If we're less than 4 months away from NPRM, won't the fun start once it's announced? What's the timeline for BT- 1 year?
After the NPRM, don't you think anything can happen with our IP in terms of investment, buy out, or licensing?
After 3.5 years, he received a promotion. Is it that ludicrous?
Is there a record of people receiving internal promotions after 3-6 months? Or some personnel, after several years of diligence and dedication?
See you in October.
bump 2
You don't think it's a good idea to hire a team of experts to amplify our IP in that arena?
Well I'm not saying they're literally waiting... I'm sure they've got to eat
I've overused the phrase by now, but everything is culminating... the visibility of cigarette's health effects... the movement of information to the public... the science... a health-crazed culture... the yearly 5% drop in cig. use, anyway... the unpopularity of politicians accepting $ from BT... and more and more and more and more and more...
But who has the time? See you in October.
Feel free to read my previous posts
Waiting on the FDA for VLN... obviously
Hemp... who cares at this point... waiting on the FDA for VLN... October 2019
Actually, I've now been dead on, 2 for 2... happyjohn1! Congrats! NPRM coming 10/2019! Click and read! *hugs*
https://www.reginfo.gov/public/do/eAgendaViewRule?pubId=201904&RIN=0910-AH86
The NPRM status link is right here, dude...
https://www.reginfo.gov/public/do/eAgendaViewRule?pubId=201904&RIN=0910-AH86
NPRM... 10/00/2019
I happened to find it because I read articles on nicotine... I'm surprised no one gives a hoot
FDA Finalizes Guidance on Premarket Tobacco Product Applications for ENDS
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/premarket-tobacco-product-applications-electronic-nicotine-delivery-systems-ends?utm_source=Eloqua&utm_medium=email&utm_term=stratcomms&utm_content=guidance&utm_campaign=CTP%20News%3A%20PMTA%20ENDS%20Guidance%20-%2061119
Let's talk once the nicotine mandate is passed
It'll simplify the debate ;)
Global Forum on Nicotine (GFN) 2019 - Perfect... this is happening in June (prior to October...)... like I said Tommy, it's all culminating... look to the past but quit living in it... changes are coming
Global experts to debate on use of safer nicotine products
https://www.business-standard.com/article/pti-stories/global-experts-to-debate-on-use-of-safer-nicotine-products-119060900418_1.html
Nicotine from e-cigarettes may damage ability to clear mucus from airways
https://www.upi.com/Health_News/2019/06/07/Nicotine-from-e-cigarettes-may-damage-ability-to-clear-mucus-from-airways/5041559909394/
PMTA/MRTP approvals upcoming catalysts... we're looking good... $10-20 range for buy-out pending BT interest in our IP
Hurray! Congrats Longs! Congrats Gio, Tommy!
GLTA
https://www.reginfo.gov/public/do/eAgendaViewRule?pubId=201904&RIN=0910-AH86
There's your answer, Gio!
Woah! Just saw this? Rule in October 2019???
The proposed rule, set to be published in October 2019, would lower nicotine levels in cigarettes and certain other combusted tobacco products to make them minimally addictive. The largest cigarette-selling tobacco companies have already opposed the rule, arguing that it would prompt a new illicit trade in non-complying full nicotine cigarettes that is larger than the current illicit trade in tax-evading cigarettes.
http://oneill.law.georgetown.edu/news/illicit-trade-risks-too-small-and-weak-to-delay-fda-rule-to-reduce-nicotine-in-cigarettes/
New analysis shows that any illicit trade of full-nicotine cigarettes after a new FDA rule to reduce nicotine in smoked tobacco products would be ‘too small’ to interfere with public health gains, directly contradicting tobacco industry arguments against the rule.
http://oneill.law.georgetown.edu/news/illicit-trade-risks-too-small-and-weak-to-delay-fda-rule-to-reduce-nicotine-in-cigarettes/
“Years of progress to combat youth use of tobacco is now threatened by an epidemic of e-cigarette use by kids, and unfortunately research shows many youth are mistaken or unaware of the risks and the presence of nicotine in e-cigarettes. That’s why it’s critical we ensure manufacturers, retailers and others are including the required health warning about nicotine’s addictive properties on packages and advertisements – especially on social media platforms popular with kids... we cannot and will not risk a generation of youth to a lifetime of nicotine addiction. We appreciate the FTC joining us on these and other actions to protect youth from the dangers of nicotine and tobacco products.” - Acting FDA Commissioner Ned Sharpless, M.D.
The FDA said this summer... did you get the TPS report?
A US Food and Drug Administration (FDA) rule setting nicotine limits for cigarettes and similarly smoked tobacco products at the lowest technically achievable levels would produce extraordinarily large and rapid smoking declines.
https://ajph.aphapublications.org/doi/10.2105/AJPH.2019.305138
Illicit Trade Poses No Threat to an FDA Rule to Minimize Nicotine in Smoked Tobacco Products
Look at the VLN delay with all the paid science...
CBD can lag too
Altria stock boosted by news of acquisition of nicotine pouch business On!
https://www.marketwatch.com/story/altria-stock-boosted-by-news-of-acquisition-of-nicotine-pouch-business-on-2019-06-03
“Due to the FDA’s pre-market approval requirements (i.e. PMTAs) Altria has not been able to introduce a competitor product to Zyn,” Elliott wrote.
Cannabis stocks fall after FDA hearing on CBD finds conflicting views of substance
https://www.marketwatch.com/story/cannabis-stocks-fall-after-fda-hearing-on-cbd-finds-conflicting-views-of-substance-2019-06-03
The hearing “highlighted the messy state of the industry, with widespread use of CBD products with minimal standardization, evidence for benefit and understanding of safety profile,” said Evercore ISI analysts led by Josh Schimmer in a note to clients.
...profiles, where have I seen this before:
22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content tobacco, and hemp/cannabis research, announced today that the Company has entered into a worldwide strategic research and development agreement with KeyGene, www.keygene.com, a global leader in plant research involving high-value genetic traits and increased crop yields. This exclusive, worldwide collaboration will focus on developing hemp/cannabis plants with exceptional cannabinoid profiles for medical and therapeutic use among other applications.
https://marijuanastocks.com/xxii-announces-exclusive-worldwide-agreement-with-keygene/
I hear you all
My gut tells me til end of summer is a sensible, possible timeline for catalysts to impact share price
Trust the gut
Study: E-cig flavors pose health threat to cardiovascular system
https://www.wraltechwire.com/2019/05/28/study-e-cig-flavors-pose-health-threat-to-cardiovascular-system/
FDA’s Center for Tobacco Products: 10 Years of Protecting Public Health through Regulation
Just 10 years ago, in June 2009, Congress passed the Tobacco Control Act granting FDA regulatory oversight of tobacco products. Prior to this historic action, tobacco companies were mostly exempt from federal product regulation. There was no federal law preventing tobacco companies from selling their products to children, though states were required to enact such laws to receive some federal grants. There was no pre-market scientific review of the health effects of new tobacco products coming onto the market. Tobacco companies were free to make unproven claims of reduced risk or harm.
In 2009, when the Tobacco Control Act was signed, everything changed. FDA was given powerful tools to help reduce the disease and death caused by the use of tobacco products. One way FDA accomplishes this is through regulation: rules that tobacco manufacturers, retailers, distributors, and importers must follow, and guidances that provide the tobacco industry with the most current thinking from FDA to help ensure they are in compliance with the law.
In August 2009, FDA established the Center for Tobacco Products and in September 2009, just three months after the Tobacco Control Act was signed into law, FDA implemented a statutory ban on cigarettes with characterizing flavors other than menthol, such as fruit, candy or clove, which Congress had recognized as appealing to kids. Six months later, FDA carried out another Congressional directive by publishing its first finalized regulation—or final rule—prohibiting the sale and distribution of cigarettes and smokeless tobacco to anyone under the age of 18. The rule also required a photo ID for tobacco sales, prohibited free samples and vending machine sales (with some exceptions), prohibited tobacco company promotional items such as hats and tee shirts, and prohibited tobacco company sponsorship of sporting events.
In the following years, FDA continued to issue other rules related to the manufacture, distribution, and marketing of tobacco products, such as establishing a methodology to assess user fees that the statute requires tobacco companies to pay to fund FDA’s work.
In 2016, FDA finalized the historic “Deeming Rule,” which extended the agency’s regulatory authority to all tobacco products (other than accessories), including electronic nicotine delivery systems (ENDS) like e-cigarettes. Thanks to this regulation, retailers can no longer sell e-cigarettes, or any other product made or derived from tobacco, to anyone under 18. In addition, manufacturers must now provide FDA with information about what these previously unregulated products contain and how they impact public health, which, in turn, informs future regulatory decision-making.
Finalizing a regulation is an involved, well-considered process that can sometimes take several years. Before publishing a final rule, FDA first publishes a proposed rule, soliciting comments from the public. As an additional step, FDA sometimes chooses to solicit comment even earlier in the process by issuing an Advance Notice of Proposed Rulemaking (ANPRM).
In March 2018, three ANPRMs were issued, including one to obtain information about a potential tobacco product standard that would lower the nicotine in cigarettes to a minimally or non-addictive level. Such a standard could drastically help addicted adult smokers in their efforts to quit and, importantly, prevent children from ever becoming addicted to cigarettes. The other two ANPRMs sought information to help inform FDA’s regulation of certain flavors in tobacco products—including flavors in e-cigarettes—and premium cigars, respectively.
FDA is committed to issuing foundational rules to make the science-based product review process more efficient, predictable, and transparent for manufacturers, while advancing the agency’s public health mission. Earlier this year, FDA issued a proposed rule that details the content and format for submitting a Substantial Equivalence report to the Agency. FDA is also continuing to work on other foundational rules and guidances, including regulations outlining what should be included in Premarket Tobacco Product Applications (PMTA) and Modified Risk Tobacco Product (MRTP) applications.
Since its inception, FDA’s Center for Tobacco Products has finalized 11 rules, issued 11 proposed rules, and published 29 final guidances. FDA regulations are science-based and intended to support the Agency’s mission of reducing the negative impact of tobacco use on the nation’s health. Grounded in scientific research, and with public input taken into consideration, each regulation put forth by FDA is intended to help protect the American public from the harms of tobacco with the goal that one day future generations will not know the burden of tobacco-related disease and death.
Philip Morris going totally smokeless, looks to quit nicotine, executive says
https://www.foxbusiness.com/healthcare/philip-morris-going-totally-smokeless-looks-to-quite-nicotine
Summer 2019 begins June 21 and ends Sept. 23
If nothing- then we're done here
And I don’t care to post as much... when it hits it will hit- this summer.
That's not a hit... that's a middle school paper...